Durgical
EN
Open the app

Preventing clots in hospital: VTE risk, bleeding risk and thromboprophylaxis

  • Diagnostic approach

Patients in hospital are among those most likely to get clots in the legs and lungs, and most of these clots can be prevented by matching protection to risk.

Updated

What it is

Thromboprophylaxis is the prevention of deep vein thrombosis and pulmonary embolism in people at temporary high risk, above all hospitalised surgical and medical patients. Every adult admission gets two assessments: the risk of a clot, with a validated score (Caprini for surgical patients, Padua for medical patients), and the risk of bleeding. The answer is early mobilisation alone, a drug (usually a low-molecular-weight heparin), a mechanical method (intermittent pneumatic compression or stockings), or both, for a length of time set by the guideline.

Red flags

  • More than a third of the clots diagnosed each year are linked to a recent hospital stay, most of them after discharge, and many are preventable.
  • Highest-risk surgery: hip or knee replacement, hip fracture, major abdominal or pelvic cancer surgery, major trauma and acute spinal cord injury.
  • Medical patients: active cancer, previous VTE, reduced mobility and a known thrombophilia weigh most in the Padua score; heart or respiratory failure, acute infection, stroke, age and obesity add to them.
  • Bleeding red flags: active bleeding, a recent gastroduodenal ulcer or bleed, very low platelets, severe liver or kidney failure, recent brain or spinal surgery or bleeding, and a planned spinal or epidural procedure.
  • In a Bogotá internal medicine audit, the most frequent error was giving prophylaxis to low-risk patients, followed by omitting it in patients who needed it.

The decision tree, step by step

  1. On admission, score clot risk: Padua for acutely ill medical patients, Caprini (or a similar surgical tool) for surgical patients.
  2. Score bleeding risk at the same time: IMPROVE bleeding in medical patients; procedure and patient factors in surgical ones.
  3. Low clot risk: early mobilisation and fluids; no drug.
  4. High clot risk, acceptable bleeding risk: a drug, usually a low-molecular-weight heparin; in high-risk surgery a mechanical method can be added.
  5. High clot and high bleeding risk: intermittent pneumatic compression, then a drug once the bleeding risk falls.
  6. Adjust for kidney function, cancer, pregnancy, current anticoagulation and spinal anaesthesia; reassess at each change and at discharge.

Three scores that are easy to mix up

FeatureCapriniPaduaIMPROVE bleeding
Who it is forSurgical inpatients (clot risk)Acutely ill medical inpatients (clot risk)Acutely ill medical inpatients (bleeding risk)
What it adds upAbout 40 items: age, type and length of surgery, cancer, previous or family VTE, thrombophilia, fractures and trauma, immobility, cast, central line, obesity, pregnancy and the postpartum period, hormones, sepsis, heart and lung disease11 items: active cancer, previous VTE, reduced mobility and known thrombophilia (heaviest), recent trauma or surgery, older age, heart or respiratory failure, myocardial infarction or stroke, acute infection or rheumatic disease, obesity, hormone treatmentActive gastroduodenal ulcer, bleeding in the previous three months, low platelets, age, liver failure, kidney failure, intensive care stay, central line, rheumatic disease, active cancer, male sex
High means5 or more (high risk): a drug, often with a mechanical method if bleeding risk allows4 or more (high risk): a drug unless bleeding risk is high7 or more (high bleeding risk): prefer a mechanical method
What it does not tell youWhich drug, the regimen or the durationNot validated for intensive care or every special groupSurgical bleeding risk, which depends on the operation

In clinical practice

  • A 72-year-old in bed with pneumonia and heart failure is high risk on Padua; with no bleeding risk, a low-molecular-weight heparin while in hospital, usually stopped at discharge.
  • A trauma patient with an unstable splenic injury: intermittent pneumatic compression at once, then a drug as soon as the bleeding is controlled.
  • If a low-molecular-weight heparin cannot be used, unfractionated heparin or fondaparinux are the usual alternatives; the duration is set by the guideline.
  • Kidney impairment: low-molecular-weight heparins and fondaparinux are cleared by the kidney and build up when function is severely reduced, so unfractionated heparin or an adjusted regimen is used, as set by the guideline.
  • Cancer: an inpatient with active cancer is assessed like any medical patient, and the cancer alone makes the risk high; for outpatients starting chemotherapy, the Khorana score helps select who may benefit.
  • Pregnancy and the postpartum period, especially after a caesarean section, are high-risk states with their own risk assessment; low-molecular-weight heparin is the drug used, while warfarin and oral direct anticoagulants are avoided in pregnancy.
  • Patients already on therapeutic anticoagulation (for example for atrial fibrillation) need no added prophylaxis; spinal and epidural procedures need the heparin timing agreed with anaesthesia.

Tests and next step

  • Before starting: full count (platelets), creatinine for kidney clearance, and clotting tests when bleeding risk is unclear.
  • On heparin: platelet monitoring as the guideline sets it, because heparin-induced thrombocytopenia causes clots, not bleeding.
  • Re-score clot and bleeding risk at each change in condition and at discharge, and document the decision.
  • Suspected DVT or PE despite prophylaxis: switch to the diagnostic pathway (probability, D-dimer, imaging) and to a treatment plan.

Common traps

  • Prophylaxis and treatment use the same drug, so the plan is the same: prophylactic intensity is far lower, and a proven clot needs a treatment plan instead.
  • Every inpatient should get heparin: low-risk patients gain nothing and carry only the bleeding risk; overuse in low-risk patients is the commonest prescribing error.
  • Stockings protect as well as a drug: in most patients a drug works better; mechanical methods are for when bleeding risk is too high, and intermittent compression beats stockings.
  • Discharge ends the risk: most hospital-linked clots appear after discharge; selected surgical patients get extended prophylaxis, while medical patients usually stop at discharge.
  • Low-molecular-weight heparin is safe at any kidney function: it builds up in severe kidney impairment, so the drug or regimen is changed as the guideline sets.

Test yourself

Think of the answer, then tap the question to see it.

A medical inpatient has a Padua score of 5 and an IMPROVE bleeding score of 8. What prophylaxis is suitable, and why?

Mechanical prophylaxis, preferably intermittent pneumatic compression: the clot risk is high but so is the bleeding risk; switch to a drug once the bleeding risk falls.

Why is the kidney function checked before choosing the prophylactic drug?

Low-molecular-weight heparins and fondaparinux are cleared by the kidney and accumulate when function is severely reduced, raising the bleeding risk; unfractionated heparin or an adjusted regimen is then used.

Which four Padua items carry the most weight?

Active cancer, previous VTE, reduced mobility and a known thrombophilia; any one of them plus another risk factor makes the patient high risk.

A patient on heparin prophylaxis develops a new clot and a falling platelet count. What should you suspect?

Heparin-induced thrombocytopenia: an immune reaction that activates platelets and causes thrombosis; heparin is stopped and a non-heparin anticoagulant is used.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients (Blood Advances (PMC open access), 2018); American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients (Blood Advances (PMC open access), 2019); Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model (Journal of Atherosclerosis and Thrombosis (PMC open access), 2018); Understanding Your Risk for Healthcare-Associated VTE (Blood Clots) (Centers for Disease Control and Prevention (CDC), 2024); Tromboprofilaxis en el paciente médico hospitalizado por medicina interna: un estudio de corte transversal (Acta Médica Colombiana, 2015).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.